ArticleBMC ophthalmology2026
Preliminary clinical observation of unilateral implantation of trifocal intraocular lens.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEvidence on unilateral trifocal IOL implantation is limited. This study evaluates the clinical outcomes of unilateral implantation of the AcrySof IQ PanOptix TFNT00 trifocal intraocular lens (IOL) in cataract patients.
methodsThis study included 55 eyes of 55 cataract patients who underwent unilateral TFNT00 trifocal IOL implantation. Comprehensive evaluations were performed preoperatively and postoperatively at 1, 3, 6, and 12 months. Outcome measures included uncorrected distance visual acuity (UDVA), uncorrected intermediate visual acuity (UIVA), uncorrected near visual acuity (UNVA), and corrected distance visual acuity (CDVA); defocus curve analysis; objective optical quality parameters, including Strehl ratio (SR) and modulation transfer function area ratio (MTF-AR); reading performance; and dysphotopsia. Subjective visual function was quantified using the VF-14 Cataract Visual Function Questionnaire at 1 and 12 months postoperatively.
resultsAt 12 months postoperatively, 76.4% of eyes achieved UDVA of 20/20 or better and 87.3% achieved a CDVA of 20/20 or better (≤ 0.0 logMAR). All eyes achieved UIVA and UNVA of 20/40 or better (≤ 0.3 logMAR). Refractive outcomes were stable and accurate, with 74.5% of eyes within ± 0.50 D of target spherical equivalent and a mean residual astigmatism of 0.25 ± 0.25 D at 12 months. Defocus curves demonstrated a bimodal profile with peaks at 0.00 to -0.50 D and - 2.00 to -2.50 D. Significant improvements were observed in objective optical quality parameters, Strehl ratio (SR) improved from 0.008 ± 0.007 preoperatively to 0.093 ± 0.023 at 12 months (P < 0.001), and modulation transfer function area ratio (MTF-AR) increased from 0.169 ± 0.060 to 0.413 ± 0.077 (P < 0.001). Reading performance showed marked enhancement in both reading acuity and speed (both P < 0.001). VF-14 questionnaire scores exceeded 3 points for all items. Glare or halos were reported by 3 eyes (5.5%) at 12 months; severity was not formally graded.
conclusionUnilateral implantation of the TFNT00 trifocal IOL effectively restores distance, intermediate, and near vision in cataract patients, with favorable objective optical quality and a low incidence of photic phenomena. Patients reported satisfactory subjective visual function across a wide range of daily activities, suggesting effective neuroadaptation despite monocular correction. These preliminary findings support unilateral trifocal IOL implantation as a viable option for patients in whom bilateral surgery is not feasible or desired. However, given the exploratory nature of this study, further comparative research with larger cohorts is warranted to confirm these outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.